SHARE

National Institutes of Health

Image of blue and purple cells against black background.

The partnership between DOE and the National Cancer Institute, a part of the National Institutes of Health, began in 2016 with the goal of applying HPC resources, deep learning models, and computational simulations to advance cancer research. The partnership is part of the Cancer Moonshot and includes several interdisciplinary projects: MOSSAIC, ADMIRRAL, IMPROVE, and ATOM. 

The NCI-DOE partnership is working to advance HPC to support the NCI's cancer treatment and research efforts, including targeting of drug therapy, dynamic simulation for drug discovery and development, and optimization of cancer therapies through secure, big data analysis of patient databases. The HPC capabilities of ORNL and NCCS — including data storage and the CITADEL security framework — allow research projects using sensitive patient data unprecedented use of the supercomputers, leading to critical scientific breakthroughs.